a public good project by the
Synthesis
Company
of California

© 2026

Bonnie W. Ramsey | doi.page

0 works0 citations0 h-index

Bonnie W. Ramsey

Seattle Children's Hospital(US)University of Washington(US)Seattle Children's Hospital(US)Seattle University(US)

Publications by Year

Research Areas

Cystic Fibrosis Research Advances, Neonatal Respiratory Health Research, Tracheal and airway disorders, Inhalation and Respiratory Drug Delivery, Pneumonia and Respiratory Infections

Most-Cited Works

→ A CFTR Potentiator in Patients with Cystic Fibrosis and the G551D Mutation(2011)2,161 cited
→ Elexacaftor–Tezacaftor–Ivacaftor for Cystic Fibrosis with a Single Phe508del Allele(2019)2,037 cited
→ Pathophysiology and Management of Pulmonary Infections in Cystic Fibrosis(2003)1,628 cited
→ Lumacaftor–Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508delCFTR(2015)1,609 cited
→ Effect of Aerosolized Recombinant Human DNase on Exacerbations of Respiratory Symptoms and on Pulmonary Function in Patients with Cystic Fibrosis(1994)1,522 cited
→ Genetic adaptation by Pseudomonas aeruginosa to the airways of cystic fibrosis patients(2006)1,343 cited

→ Efficacy and safety of the elexacaftor plus tezacaftor plus ivacaftor combination regimen in people with cystic fibrosis homozygous for the F508del mutation: a double-blind, randomised, phase 3 trial(2019)

1,322 cited

→ Intermittent Administration of Inhaled Tobramycin in Patients with Cystic Fibrosis(1999)1,295 cited

→ Pseudomonas aeruginosa and other predictors of mortality and morbidity in young children with cystic fibrosis(2002)1,000 cited

→ Effect of VX-770 in Persons with Cystic Fibrosis and the G551D- CFTR Mutation(2010)801 cited